Authors
Latest:
Charitable Assistance Among Economically Vulnerable Cancer Patients: Patient Access Network Foundation Summary Statistics 2011-2015This report shows that among people who are eligible for charitable assistance to cover out-of-pocket (OOP) prescription drug expenses, those with cancer have higher per-claim and per-person OOP costs than their counterparts with other health conditions.
Latest:
Predicting Hospitalizations for Patients With Chronic Kidney DiseaseThe authors developed an algorithm that uses medical claims to identify patients with chronic kidney disease who are at greatest risk of being hospitalized within 90 days.
Latest:
Prescribing Trend of Pioglitazone After Safety Warning Release in KoreaThe pioglitazone safety warning issued in South Korea, which recommended prescribing with careful attention among those with high risk of bladder cancer, led to a moderate decrease in pioglitazone users.
Latest:
Acupuncture and Chiropractic Care: Utilization and Electronic Medical Record CaptureMost patients with chronic musculoskeletal pain use acupuncture or chiropractic care. A substantial percentage of this utilization, however, is not captured by the electronic medical record.
Latest:
Voice Response System to Measure Healthcare Costs:A STAR*D ReportModerate underreporting biases were found when patient responses to an interactive voice response system were compared with medical records in the STAR*D clinical trial.
Latest:
Real-Time Video Detection of Falls in Dementia Care Facility and Reduced Emergency CareAn artificial intelligence–enabled video fall detection system using visual science reduced emergency department visits by 80% in 6 communities over 3 months.
Latest:
Evaluation of the Quality Blue Primary Care Program on Health OutcomesImplementation of the Quality Blue Primary Care program in Louisiana was associated with a shift in primary care delivery and reductions in overall cost.
Latest:
The Wider Public Health Value of HCV Treatment Accrued by Liver Transplant RecipientsAdvances in treatment for hepatitis C virus (HCV) have the potential to generate considerable spillover benefits to patients awaiting transplants, especially among those with non—HCV-mediated liver failure.
Latest:
Impact of Hepatitis C Virus and Insurance Coverage on MortalityThe Medicaid population has significantly higher hepatitis C virus (HCV) prevalence and mortality rates than patients with private insurance. These data must be considered when policy makers assess providing additional support to Medicaid programs for HCV elimination.
Latest:
The Utility of Cost Discussions Between Patients With Cancer and OncologistsMany patients with cancer desire cost discussions with doctors, but those discussions are rare. Nevertheless, cost discussions may lower patient costs-usually without altering treatment.
Latest:
Drivers of Excess Costs of Opioid Abuse Among a Commercially Insured PopulationThe healthcare burden of opioid abuse is substantial; abusers often have complex healthcare needs and may require care beyond that which is required to treat abuse.
Latest:
Higher 30-Day and 60-Day Readmissions Among Patients Who Refuse Post Acute Care ServicesAlthough patients who refuse post acute care services are relatively young, well educated, and healthy, they are twice as likely to have 30- and 60-day readmissions compared with acceptors of services.
Latest:
The National Oncology Working Group (NOW) Initiative: Payer and Provider Collaborations in Oncology Benefits ManagementThis article highlights the work of the National Oncology Working Group (NOW) Initiative.
Latest:
Thirty-Day Readmissions: Relationship to Physician Attending Type and Social ConnectednessThis study examined patient clinical and demographic characteristics, healthcare system factors, and patients’ experiences of care associated with 30-day readmissions in a hospital with a Pioneer Accountable Care Organization.
